drugset / Trial / NCT03421613

3VM1001 Cream for the Treatment of Pain Associated With Post Herpetic Neuralgia (PHN)

NCT03421613 ↗

Phase 0 Completed 28 enrolled CDA Research Group, Inc.
RandomizedCrossoverDouble-blindTreatment

Summary

Post-herpetic neuralgia (PHN) is pain following acute herpes zoster; defined as pain lasting longer than 3 months. Current first line management consists of tricyclic anti-depressants and anti-convulsants such as gabapentin and pregabalin. There is an unmet medical need for treatments got topical therapies that demonstrate efficacy without serious side effects.

Timeline

Start
2017-03-06
Primary completion
2018-03-30
Completion
2018-05-04

Drugs

EvaluationDrugModalityDoseRoute
Subject 3VM1001 Unknown 2 g Topical